387 related articles for article (PubMed ID: 29898953)
1. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
Mondragon-Gonzalez R; Perlingeiro RCR
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
[TBL] [Abstract][Full Text] [Related]
2. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
[TBL] [Abstract][Full Text] [Related]
3. Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs.
Kawada R; Jonouchi T; Kagita A; Sato M; Hotta A; Sakurai H
Sci Rep; 2023 Jan; 13(1):94. PubMed ID: 36631509
[TBL] [Abstract][Full Text] [Related]
4. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
[TBL] [Abstract][Full Text] [Related]
5. Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.
Xia G; Gao Y; Jin S; Subramony SH; Terada N; Ranum LP; Swanson MS; Ashizawa T
Stem Cells; 2015 Jun; 33(6):1829-38. PubMed ID: 25702800
[TBL] [Abstract][Full Text] [Related]
6. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
[TBL] [Abstract][Full Text] [Related]
7. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
[TBL] [Abstract][Full Text] [Related]
8. Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells.
Loro E; Rinaldi F; Malena A; Masiero E; Novelli G; Angelini C; Romeo V; Sandri M; Botta A; Vergani L
Cell Death Differ; 2010 Aug; 17(8):1315-24. PubMed ID: 20431600
[TBL] [Abstract][Full Text] [Related]
9. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
André LM; van Cruchten RTP; Willemse M; Wansink DG
PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
[TBL] [Abstract][Full Text] [Related]
10. Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytes.
Spitalieri P; Talarico RV; Caioli S; Murdocca M; Serafino A; Girasole M; Dinarelli S; Longo G; Pucci S; Botta A; Novelli G; Zona C; Mango R; Sangiuolo F
J Mol Cell Cardiol; 2018 May; 118():95-109. PubMed ID: 29551391
[TBL] [Abstract][Full Text] [Related]
11. Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
Gao Y; Guo X; Santostefano K; Wang Y; Reid T; Zeng D; Terada N; Ashizawa T; Xia G
Mol Ther; 2016 Aug; 24(8):1378-87. PubMed ID: 27203440
[TBL] [Abstract][Full Text] [Related]
12. Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy.
Chen G; Masuda A; Konishi H; Ohkawara B; Ito M; Kinoshita M; Kiyama H; Matsuura T; Ohno K
Sci Rep; 2016 Apr; 6():25317. PubMed ID: 27126921
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclooxygenase-1 by nonsteroidal anti-inflammatory drugs demethylates MeR2 enhancer and promotes Mbnl1 transcription in myogenic cells.
Huang K; Masuda A; Chen G; Bushra S; Kamon M; Araki T; Kinoshita M; Ohkawara B; Ito M; Ohno K
Sci Rep; 2020 Feb; 10(1):2558. PubMed ID: 32054946
[TBL] [Abstract][Full Text] [Related]
14. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
Michel L; Huguet-Lachon A; Gourdon G
PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
[TBL] [Abstract][Full Text] [Related]
15. Reliable and versatile immortal muscle cell models from healthy and myotonic dystrophy type 1 primary human myoblasts.
Pantic B; Borgia D; Giunco S; Malena A; Kiyono T; Salvatori S; De Rossi A; Giardina E; Sangiuolo F; Pegoraro E; Vergani L; Botta A
Exp Cell Res; 2016 Mar; 342(1):39-51. PubMed ID: 26905645
[TBL] [Abstract][Full Text] [Related]
16. Myotonic dystrophy type 1 embryonic stem cells show decreased myogenic potential, increased CpG methylation at the DMPK locus and RNA mis-splicing.
Franck S; Couvreu De Deckersberg E; Bubenik JL; Markouli C; Barbé L; Allemeersch J; Hilven P; Duqué G; Swanson MS; Gheldof A; Spits C; Sermon KD
Biol Open; 2022 Jan; 11(1):. PubMed ID: 35019138
[TBL] [Abstract][Full Text] [Related]
17. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)
André LM; van Cruchten RTP; Willemse M; Bezstarosti K; Demmers JAA; van Agtmaal EL; Wansink DG; Wieringa B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766224
[TBL] [Abstract][Full Text] [Related]
18. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol increases MBNL1 expression and alleviates myotonic dystrophy phenotypes in HSA
Huang K; Wang DD; Hu WB; Zeng WQ; Xu X; Li QX; Bi FF; Yang H; Qiu J
J Transl Med; 2022 Dec; 20(1):588. PubMed ID: 36510245
[TBL] [Abstract][Full Text] [Related]
20. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
Martineau L; Racine V; Benichou SA; Puymirat J
Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
